Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jan;29(1):e13170.
doi: 10.1111/ecc.13170. Epub 2019 Sep 30.

Patients with head and neck cancer: Are they frailer than patients with other solid malignancies?

Affiliations
Observational Study

Patients with head and neck cancer: Are they frailer than patients with other solid malignancies?

Linda Bras et al. Eur J Cancer Care (Engl). 2020 Jan.

Abstract

Objective: We aimed to compare frailty status between patients with head and neck cancer (HNC) and other solid malignancies.

Methods: Data collection was prospective, and the following were compared between cohorts at baseline: patient and tumour characteristics, Charlson Comorbidity Index (CCI), Groningen Frailty Indicator (GFI), Mini Mental State Examination (MMSE), Activities of Daily Living (ADLs), Instrumental ADLs (IADLs), Timed Up and Go (TUG) and Quality of Life (QoL). Univariate and multivariate logistic regression analyses were performed, and odds ratios (ORs) with their 95% confidence intervals (95% CIs) were estimated.

Results: In total, 242 patients with HNC and 180 with other oncology diagnoses were enrolled, of whom 32.6% and 21.8% were frail according to the GFI respectively. Comorbidity scores were not significantly different between the cohorts (7.4% vs. 13.1%; OR 0.54; 95% CI 0.28-1.02). In the univariate analysis, the GFI was significantly worse in the HNC cohort (OR 1.74; 95% CI 1.11-2.71). However, in the multivariate analysis, the MMSE, TUG and global QoL were significantly worse in the HNC cohort, with ORs of 20.03 (95% CI 2.44-164.31), 11.56 (95% CI 1.86-71.68) and 0.98 (95% CI 0.97-1.00) respectively.

Conclusion: Patients with HNC appear to be frailer than patients with other solid malignancies despite comparable levels of comorbidity.

Keywords: frail elderly; frailty; geriatric assessment; geriatric oncology; head and neck cancer; quality of life.

PubMed Disclaimer

Conflict of interest statement

All authors have no conflict of interest to declare.

References

    1. Aaronson, N. K. , Ahmedzai, S. , Bergman, B. , Bullinger, M. , Cull, A. , Duez, N. J. , … Takeda, F. (1993). The european organization for research and treatment of cancer QLQ‐C30: A quality‐of‐life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. 10.1093/jnci/85.5.365 - DOI - PubMed
    1. American Joint Committee on Cancer (AJCC) (2010). What is cancer staging?. Retrieved from https://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging..... Accessed 30/11, 2017.
    1. Bøje, C. R. , Dalton, S. O. , Primdahl, H. , Kristensen, C. A. , Andersen, E. , Johansen, J. , … Overgaard, J. (2014). Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 110(1), 91–97. 10.1016/j.radonc.2013.11.009 - DOI - PubMed
    1. Bras, L. , Peters, T. , Wedman, J. , Plaat, B. , Witjes, M. , van Leeuwen, B. L. , … Halmos, G. B. (2015). Predictive value of the groningen frailty indicator for treatment outcomes in elderly patients after head and neck, or skin cancer surgery in a retrospective cohort. Clinical Otolaryngology: Official Journal of ENT‐UK; Official Journal of Netherlands Society for Oto‐Rhino‐Laryngology & Cervico‐Facial Surgery, 40(5), 474–482. 10.1111/coa.12409 - DOI - PubMed
    1. Charlson, M. E. , Pompei, P. , Ales, K. L. , & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. 10.1016/0021-9681(87)90171-8 - DOI - PubMed

Publication types

MeSH terms